The specifidty of antibody (Ab) responses depends on focusing helper T (Th) lymphocyte signals to suitable B lymphocytes capable of binding foreign antigens (Ags), and away from nonspecific or self-reactive B cells. To investigate the molecular mechanisms that prevent the activation of self-reactive B lymphocytes, the activation requirements of B cells specific for the Ag hen egg lysozyme (HEL) obtained from immunoglobulin (Ig)-transgenic mice were compared with those of functionally tolerant B cells isolated from Ig-transgenic mice which also express soluble HEL. To eliminate the need for surface (s)Ig-mediated Ag uptake and presentation and allow the effects of slg signaling to be studied in isolation, we assessed the ability of allogeneic T cells from bm12 strain mice to provide in vivo help to C57BL/6 strain-transgenic B cells. Interestingly, nontolerant Ig-transgenic B cells required both allogeneic Th cells and binding of soluble HEL for efl~dent activation and Ab production. By contrast, tolerant self-reactive B cells from Ig/HEL double transgenic mice responded poorly to the same combination of allogeneic T cells and soluble HEL. The tolerant B cells were nevertheless normally responsive to stimulation with interleukin 4 and anti-CD40 Abs in vitro, suggesting that they retained the capacity to respond to mediators of T cell help. However, the tolerant B cells exhibited a proximal block in the slg signaling pathway which prevented activation of receptor-assodated tyrosine kinases in response to the binding of soluble HEL. The functional significance of this slg signaling defect was confirmed by using a more potent membrane-bound form of HEL capable of triggering slg signaling in tolerant B cells, which markedly restored their ability to collaborate with allogeneic Th cells and produce Ab. These findings indicate that Ag-specific B cells require two signals for mounting a T cell-dependent Ab response and identify regulation of slg signaling as a mechanism for controlling self-reactive B cells.
T he ability to distinguish between self and foreign Ags is a central feature of immune recognition, allowing immunity to be acquired against foreign organisms while avoiding destructive autoimmunity. Studies of self-nonself discrimination in recent years (for reviews see references 1-3) have confirmed the clonal selection theory proposed by Bumet (4), which hypothesized that foreign Ags provoke immunity by triggering clonal expansion and differentiation of Agbinding B and T lymphocytes, whereas self-Ags induce tolerance by triggering elimination or inactivation of self-reactive cells. Although these advances provide a cellular framework for understanding self-nonselfdiscrimination, the molecular mechanisms that dictate the choice between lymphocyte activation or tolerance neverthdess remain to be defined. Understanding the molecular basis for these cellular decisions will be important for controlling the immunogenicity or tolerogenicity of vaccines, tumors, and tissue transplants, and for understanding the breakdown of stir-tolerance in autoimmune diseases.
The decision between lymphocyte activation and tolerance seems particularly approachable in B lymphocytes, since much is already known about the cellular and molecular events causing B cells to proliferate and differentiate into Ab-secreting plasma cells in response to foreign Ags. For many foreign Ags, Th cells play a key role in promoting B cell proliferation and Ab production, by adhering to suitable B cells and transmitting a set of B cell growth and differentiation signals. One of the most important signals is an integral membrane protein, CD40-1igand (CD40L) 1, that is transiently displayed on the surface of activated Th cells and triggers B cell proliferation through a receptor, CD40, constitutively expressed on B cells (5, 6) . Other molecules secreted by activated Th cells, such as IL-4 and -10, synergize with CD40L in promoting B cell proliferation and in triggering isotype switching and differentiation into plasma cells (for a recent review see reference 7) .
Since the receptors for CD40L, IL-4, and IL-IO are constitutively expressed on all B cells, development of an effective Ab response depends on preferential delivery of these helper signals to useful B cells whose surface Ig (sIg) bind foreign Ag, and not to useless B calls that do not bind Ag or to potentially harmful B cells that bind sdf-Ags. The specificity of T cell help is directed, at least in part, by the requirement that Th cells recognize a complex composed of foreign Ag peptide fragments and class II MHC molecules, that is displayed on the surface of potential B cell targets (8) (9) (10) (11) (12) . Recognition of peptide-MHC complexes by the TCR strengthens the interaction between T and B cells (13) , triggers CD40L expression (6, 14) , and polarizes IL secretion to the point of synapsis between T and B cells (15, 16) . Since B cells that bind foreign Ags are more efficient at internalizi,ng these Ags than other nonbinding B cells, Ag-specific B cells are most likely to present foreign peptide fragments and trigger delivery of T cell help (for a review see reference 12). Other receptor/ ligand pairs also contribute to the synapsis of T and B cells, such as the binding of LFA-1 on both T and B cell to intercellular adhesion molecule 1 (ICAM-1) on the opposing cell (13, 17, 18) or the binding of CD28 on the T cell to B7 on the B cell (19) , but their role in guiding the specificity of T-B cell interaction is not known.
The molecular mechanisms responsible for B cell tolerance are not well understood, especially in situations where selfreactive B cells become functionally inactivated (anergic) but are not physically eliminated. In this paper, we have explored the basis for tolerance in anergic self-reactive B cells by using a model developed previously (20) in which Ig gene transgenic mice, whose B lymphocytes express surface IgM and IgD specific for the Ag hen-egg lysozyme (HEL), were mated with transgenic mice expressing the soluble form of HEL. In the resulting soluble lysozyme/anti-lysozyme double (Dbl)-transgenic mice, self-reactive anti-lysozyme B cells developed normally and populated the peripheral lymphoid organs but were functionally tolerant to lysozyme. Since the tolerant B cells were present in normal numbers and expressed all of the developmentally regulated cell surface molecules thought to contribute to B cell activation, the explanation for tolerance was obscure. Here, we describe that tolerant B cells from these mice remain responsive to T cell-derived signals, but 1Abbr~tions used in this pat~': CD4OL, CD40-ligand; Dbl, double; HEL. hen-egg lysozyme; ICAM-I, intercellular adhesion molecule 1; slg, surface Ig; SA-PE, streptavidin-PE. exhibit a proximal block in B cell slg signaling after Ag binding that precludes effective collaboration with T cells. Moreover, the sIg signaling block can be partially overcome by very extensive receptor cross-linking, and this markedly restored collaboration with Th cells. These findings demonstrate a pivotal role for sIg signaling in guiding T cell-dependent Ab responses and that regulation of sIg signaling provides a mechanism for controlling self-reactive B cells.
Materials and Methods
Mice. Anti-HEL/sHEL Dbl-transgenic animals were obtained by mating transgenic animals from the MD4 anti-HEL IgM + IgD line and the ML5 soluble HEL line, which were produced and maintained on a C57BL/6J (B6) background as described (20) . To mark the Ig-or Dbl-transgenic cells with Ly5 ~, B6 MD4 x ML5 Dbl-transgenic mice were mated with C57BL/6-Ly5" congenic mice (the generous gift of Dr. I. Weissman, Stanford University, Stanford, CA), and the Ft-hybrid offspring used as spleen cell donors. Membrane (m)HEL transgenic mice were from the line KLK4 expressing lysozyme fused to class I transmembrane and cytoplasmic regions (21) . B6 and bin12 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). All mice used were between 8 and 16 wk of age.
Adoptive Transfers. Recipient mice were age matched or littermate C57BL/6J nontransgenic, sHEL transgenic (ML5 line), or mHEL transgenic (KLK4 line) mice, sublethally irradiated with 750 tad x-irradiation and injected intravenously with 107 transgenic splenocytes and 5 x 107 splenocytes from B6 or bm12 mice. Cotransfer experiments (e.g., see Fig. 2 , A-C) used the same protocol except that 107 B6-Dbl-transgenic splenocytes were injected along with 107 Ig/Ly5' splenocytes and 5 x 107 splenocytes from B6 or bin12 mice. 5 d after transfer, spleen cells from the recipients were harvested, counted by hemocytometer, stained for FACS| -),sis as described below, and the number of anti-HEL IgM' Absecreting cells enumerated by spot ELISA (22) .
In Vitro Cultures. For MLCs (see Fig. 2 D) , 10 s Ly5~-bearing splenocytes from either lg-, Dbl-, or non-transgenic mice were cultured with 5 x 10 s splenocytes from B6 mice and 5 x 100 splenocytes from bm12 mice. Cells were cultured in round-bottomed 96-well plates (Falcon) at 37"C, in 5% CO2 in 0.2 ml of RPMI media supplemented with 10% FCS, 2 mM glutamine, 50/zM 2-MEK, with or without 100 ng/ml HEL (Sigma Chemical Co., St. Louis, MO). After 4 d of culture, cells were washed free of residual HEL and the number of anti-HEL IgM ~ secreting cells determined by spot ELISA. For LPS stimulation, 20/zg/ml LPS (Escherichia coli 0111:B4; Difco Laboratories, Detroit, MI) was added to parallel cultures containing 10 s Ig-or Dbl-transgenic spleen cells. Proliferation assays used 10 s splenocytes cultured in flatbottomed 96-well plates (Linbro) in a final volume of 0.1 ml RPMI media (see Fig. 3 Flow Cytoraetry Staining and Analysis. Cell staining and threecolor FACS | analysis were conducted as described (25) . Ly5 ~ was detected using FITC-conjugated AS20 (25) and HEL-binding cells were revealed by incubating with 100 ng/ml HEL followed by HyHEL5-biotin and streptavidin-Tricolor (Caltag Laboratories, San Francisco, CA) as described (25) . Syndecan was detected with mAb 284.1 (26) followed by F(ab)2 anti-rat IgG conjugated to PE (Caltag Laboratories). Class II was detected using mAb 7-16.17 conjugated to biotin (PharMingen, San Diego, CA) followed by streptavidin-PE (SA-PE; Cahag Laboratories). CTLA4-Ig ligand was detected using 10 ~g/ml CTLA4-Ig fusion protein (27) followed by anti-human IgG-FITC (Tago Inc., Burllngame, CA). ICAM-1 was detected using mAb 3E2 conjugated to biotin (PharMingen) followed by SA-PE. Staining for B220 used Ab RA3-6B2 conjugated to either FITC or PE (Caltag Laboratories).
Calcium Analysis. Calcium analysis was conducted essentially as described (24) . Briefly, splenocytes were isolated, washed, and resuspended at 107 cells/ml in 10% FCS/RPMI and loaded with the calcium indicator Indo-lAM (1 #M, final concentration; Molecular Probes, Inc., Eugene, OR) for 30 win at 37~ Cells were subsequently washed and stained with FITC-conjugated Abs to CD4 and CD8. Indo-1 loaded cells were suspended at 5 x 106/rrd and prewarmed to 37~ immediately before analysis. Analysis was conducted at 37~ unstimulated ceils were collected for 45 s, Ag added at I min, and data collection continued for a total of 7 rain, with a flow rate of 200-400 cells/s. For mHEL stimulation (see Fig. 7 A) cells were collected for 45 s to establish basal calcium levels, cens removed, and mHEL-bearing or control thymocytes were added to a concentration of 10Vml. The mixture was pelleted for 5 s using a microfuge, resuspended using a micropipette, and data collection resumed. Thymocytes were excluded from analysis by electronically gating on Indo-1 loaded cells. CD4-or CDg-positive cells were excluded from analysis by electronic gating on FITCnegative cells. Detection of Indo-1 and FITC fluorescence used a dual hser FACStar Plus | flow cytometer (Becton Dickinson & Co.). Conversion of Indo-1 violet-blue fluorescence ratios to calcium levels was determined as described (28, 29) . Transfer of Ig or Dbltransgenic B cells into nontransgenic recipients was perforraed by intravenous injection of 107 spleen ceLls into 750 tad x-irradiated recipients. "Parked" cells were recovered from the spleen 36 h after transfer, loaded with Indo-1, and analyzed as described above.
Pkospkotyrosine lmmunoblotting. For analysis of phosphotyrosine levels, freshly isolated sphnocytes were washed, resuspended at 107/ml in serum-free RPMI, and stimulated with the indicated reagents for 5 rain at 37~ Cells were then pelleted, lysed, and lysates from 10 ~ cell equivalents were resolved on an 11% SDS-PAGE gel and immunoblotted with antiphosphotyrosine mAb 4(310 (Upstate Biotechnology Inc., Lake Placid, NY) (final concentration 1:2,000), using enhanced chemiluminescent detection as described previously (24) . (20, 21, 30) . The failure of self-reactive B cells from Dbl-transgenic mice to collaborate with SRBC-specific T cells could have reflected either a defect in their ability to take up and present lysozyme-SRBC Ag conjugates to Th cells, or a defect in the subsequent ability to interact with and receive growth and differentiation factors from T cells. To explore which of these steps was altered, the requirement for Ag binding and processing into MHC-associated peptides was bypassed by providing a constitutively expressed TCR-ligand on the B cells, using unique determinants on class II MHC molecules themsdves. B cells in C57BL/6 (]36) strain mice display I-A b MHC molecules that differ at three residues from I-A molecules in the coisogenic strain, bm12 (31) . Because of this alldic difference, a proportion of Th calls in bin12 mice carry Ag receptors that are triggered by I-A b ( Following the approach diagrammed in Fig. 1 A, spleen cells from B6 strain Dbl-and Ig-transgenic mice were marked with an alldic Ly5' cell surface marker and an IgM' Ig allotype marker to allow unequivocal identification, and were transferred to recipient animals of the B6 strain. Spleen cells from bin12 mice, including anti I-A b Th cells, were cotransferred in numbers determined to cause optimal B cell proliferation and Ab production. In the absence of any cotransferred B cells, activation of the bm12-derived T cells occurred in response to I-A b radioresistant calls in the recipients, producing marked splenomegaly and other symptoms of GVHD within 5-7 d (data not shown). When bin12 T ceils and nontolerant Ig-transgenic B cells were cotransferred into mice expressing lysozyme, the lysozyme-binding B cells were transformed into large blast cells (data not shown) and increased their numbers 10-50-fold ( Fig. 1 
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The apparent proliferation of lysozyme-binding B cells was accompanied by differentiation into Ab-secreting phsma ceUs, detected by ELISA-spot assay of spleen calls ( Fig. 1 C, bottom) .
The presence of both lysozyme and I-AS-reactive T cells was required for proliferation and differentiation of the nontolerant lysozyme-binding B cells, since neither occurred when (a) the same cell mixtures were transferred into nontransgenic recipients lacking lysozyme ( 
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Non/Ly5 a plus T cell hel~ cells was measured in parallel by staining with an Ab to the plasma cell marker, syndecan (26 and Fig. 2 C) . Nontolerant Ly5 "+ B ceils proliferated and differentiated efficiently in the presence of lysozyme and bml2 T cells (Fig. 2 , A-C, bottom righ O, confirming that activated I-Ab-spedfic Th cells were indeed generated in these recipients. By contrast, the tolerant Ly5'-B cells in the same hosts fared to undergo blastogenesis, increase in cell number or differentiate into plasma cells (Fig. 2, A-C) .
The possibility that the tolerant B cells were capable of interacting with T ceils but failed to migrate to the appropriate in vivo microenvironment was tested by performing equivalent experiments with bin12 T cells in suspension cultures in vitro. Small numbers of Ly5'-marked spleen cells from B6 Ig-or Dbl-transgenic mice were added to two-way mixed lymphocyte reactions between nontransgenic B6 and bml2 spleen cells. Again, lysozyme-binding B cells from Igtransgenic mice proliferated, as detected by blastogenesis and BrdU incorporation (data not shown) and differentiated into Ab-secreting ceils (Fig. 2/9 ) only when lysozyme was added to the cultures. Dbl-transgenic ceils, by contrast, showed little proliferation and generated 50-100-fold fewer Ab-secreting cells (Fig. 2 D and data not shown) . Parallel cultures stimulated with the nonspecific B cell mitogen, LPS, neverthdess confirmed that the tolerant B cells were potentially capable of efficient proliferation and differentiation into Ab-secreting cells (Fig. 2 D, right columns) as previously described (32) .
Tolerant B Cells Respond to T Cell-derived Mediators. Two signals appeared necessary for efficient proliferation and differentiation of nontolerant lysozyme-binding B cells under the conditions of I-Ab-specific T cell help used above: one provided by the bin12 T cells, and one resulting from the binding of lysozyme to the B cell (see Fig. 1 A) (Fig. 3 A) . Additionally, these stimuli also increased the immunofluorescent staining of both cell types with CTLA4-Ig fusion protein (Fig. 3 A) which recognizes B7 and B7-related molecules expressed on activated B cells (hereafter referred to CTLA4-Ig ligand; 34; see Discussion). Vigorous proliferation was induced in both cell types by antisera to CD40 (Fig. 3 B) , and this was augmented in both tolerant and nontolerant B cells by addition of IL4 (Fig. 3 C) . Taken (Fig. 4 A) , submitogenic concentrations of LPS (Fig. 4 B) , or suboptimal concentrations of anti-CD40 antiserum (data not shown). However, binding of lysozyme to tolerant B cells had no mitogenic effects in any of these assays (Figs. 4, A and B and not shown) . Similarly, whereas binding of lysozyme alone was not mitogenic, it promoted activation of nontolerant Ig-transgenic B cells from Go to G: of the cell cycle, as assessed by increased RNA synthesis (Fig. 4 C) or by cell enlargement detected flow cytomerrically (dam not shown). In contrast, lysozyme binding failed to induce cell enlargement or increased RNA synthesis in tolerant B cells (Fig. 4 C, and data not shown) . Finally, lysozyrne binding triggered increased expression of CTLA4-Ig ligand and ICAM-1 molecules on nontolerant Ig-transgenic cells, but induced little increase in the expression of these molecules on tolerant Dbl-transgenic cells (Fig. 4 D) .
The absence of many cellular responses to Ag binding in the tolerant cells was further explored by following early signaltransduction events normally triggered by sIg engagement. upstream to the initiation of increased [Ca]i (37) (38) (39) (40) . To measure tyrosine kinase activation, Dbl-and Ig-transgenic spleen cells were stimulated with lysozyme in vitro, and cell lysates were then prepared and probed by immunoblot using Abs specific for phosphotyrosine. Lysates from unstimulated tolerant or nontolerant cells had few phosphotyrosine-containiug proteins (Fig. 5 C) . Stimulation with concentrations of lysozyme as low as 6 ug/ml resulted in rapid appearance of many phosphotyrosine-containing proteins within the nontolerant Ig-transgenic B cells. By contrast, even saturating concentrations of lysozyme failed to induce a detectable increase in phosphotyrosine species in the tolerant B cells (Fig.   5C ).
Because of modulation of IgM Ag receptors and in vivo occupancy of many IgD receptors with lysozyme, B cells from the Dbl-transgenic mice display 3-4-fold fewer available receptors for binding additional exogenous lysozyme molecules than nontolerant B cells from Ig-transgenic mice (Fig.   5 A inset) . To test whether the signaling defects in the Dbltransgenic B cells were simply a result of fewer receptors, or alternatively, a short-term refractory phenomenon due to recent in vivo exposure to lysozyme, B ceils were removed from the Dbl-transgenic mice and "parked" in irradiated nontransgenic mice to allow bound lysozyme to dissociate. 36 h after transfer, the parked Dbl-transgenic B calls displayed a nearly equivalent capacity to bind fluorescently labeled lysozyme as did parked Ig-transgenic B ceils (Fig. 5 B, inset) .
Despite this, the tolerant ceils remained unable to increase [Ca]i after stimulation with lysozyme ( Fig. 5 B) , indicating that the defect in signaling was not due simply to receptor modulation. Whereas [Ca]i increase is an immediate consequence of tyrosine kinase activation (37) (38) (39) (40) , parked B calls could not be recovered in suflfident numbers or purity to measure protein tyrosine phosphoryhtion directly.
Defective Response of Tolerant B Cells to anti-IgD Abs.
The absence of intracellular signaling events after HEL binding to tolerant B cells was fimher egplored by stimulating tolerant and nontolerant B ceils with affinity-purified Abs to the C regions of IgD. Stimulation by anti-IgD differed from lysozyme stimulation in that IgD is expressed at identical levels on tolerant and nontolerant B cells, is equally accessible to anti-C region Abs, and thexefore should be cross-linked equally weU on the two cell types. Additionally, the polydonal antiIgD Abs should promote extensive receptor cross-linking and therefore would test whether tolerant B ceils retained any capacity to signal through sIg. In contrast to stimulation with lysozyme, extensive cross-l/nking of sIgD receptors elicited some early signaling events in the tolerant B cells, although the magnitude and kinetics of the response remained altered compared with nontolerant B cells. Thus, treatment with anti-IgD antisera induced an identical pattern of phosphotyrosine-containiug proteins in both Dbl-and Ig-transgenic B cells, although the rdative abundance of labeled proteins was markedly reduced in tolerant cells (Fig. 6 A) . Similarly 10-15% for up to 4 min ( Fig. 6 B, left) . In contrast, stimulation of tolerant B cells with anti-IgD induced a more rapid initial [Ca]i response, but this response diminished much more quickly and lacked the sustained phase observed in the nontolerant B cells (Fig. 6 B, right) .
Whereas the ability of anti-IgD antisera to evoke proximal signaling events suggested that the necessary receptorassociated components were at least partially present and activatable in the tolerant B cells, more distal events such as cell cycle entry still failed to occur. Thus, stimulation with the same antiolgD antiserum failed to trigger G0-G1 transition in Dbl-transgenic cells as measured by induction of R N A synthesis (Fig. 6 C) , and promoted little D N A synthesis in the tolerant cells in combination with submitogenic concentrations of LPS (Fig. 6 D) . Similar results were obtained with mAbs to IgD coupled to dextran (41), which also cross-link Ig receptors extensively and promoted vigorous proliferation in the nontolerant Ig-transgenic B cells, but induced little or no mitogenic response in tolerant B cells (data not shown). Proliferation in response to calcium ionophore and phorbol ester, which bypass the requirement for slg signaling, remained intact in the tolerant cells (Fig. 6 E) . Whereas extensive receptor cross-linking with anti-IgD Abs was unable to promote cell cycle entry, this stimulus was nevertheless sufficient 433 Cooke et al.
to induce high expression ofCTLA4-Ig ligand on the tolerant calls (Fig. 6 F) .
Tolerant B Cells Respond to Membrane-bound Lysozyma Since
early signaling events could be partially restored and CTLA4-Ig ligand induced on the tolerant B cells after extensive receptor cross-linking with Abs to IgD, we tested whether a highly multivalent form of lysozyme expressed on ceU surfaces as an integral membrane protein (mHEL) would also restore sIg signal transduction. Thymocytes from transgenic mice expressing mHEL on cell surfaces (21) were therefore mixed with Indo-1 loaded B cells and changes in [Call measured as previously. In contrast to stimulation with soluble lysozyme which remained unable to dicit a [Call response in tolerant B calls (Fig. 7 A, 2) , stimulation with membrane lysozyme triggered a dear [Call response in both tolerantand nontolerant-transgenic B cells although the response in the latter was somewhat weaker (Fig. 7 A, 7 and 8 ). Control B6 thymocytes lacking mHEL elicited no response in either cell type (Fig. 7 A, 3 and 4). Combined stimulation with control B6 thymocytes and soluble HEL remained unable to dicit a calcium response in tolerant B cells (Fig. 7 R, 6 ), indicating that Ag display on membranes was required and that costimulatory molecules on thymocytes were not sufficient. To test whether the partial restoration of sIg signaling induced by displaying lysozyme in multimeric cell-bound form was sufficient to restore collaboration with I-Ab-specific Th cells, transgenic B cells, and bm12 T cells were transferred into recipient mice expressing mHEL. Tolerant B cells from Dbl-transgenic mice remained poorly responsive to soluble lysozyme (sHEL) and bm12 helper calls (Fig. 7, B and C, middle columns), but their helper ceil-induced proliferation and differentiation into Ab-secreting plasma cells increased 100-fold in recipients expressing mHEL (Fig. 7, B and C, right columns). The magnitude of the response mounted by tolerant B cells in the presence of mHEL was equivalent to that mounted by nontolerant Ig-transgenic B cells in the presence of sHEL, and only fivefold less than the response of the latter in mHEL recipients (Fig. 7 , B and C). Thus, display 
Discussion
The studies above localize the molecular mechanism accounting for B cell clonal anergy to a proximal step in the sIg signal transduction pathway. Moreover, the findings indicate that Ag-specific B cells require signals from T cells and from Ag binding to sIg for efficient proliferation and differentiation into Ab-secreting cells, as originally proposed by Bretscher and Cohn (42) . The conclusion that Ag-derived signals through sIg are required was based on three observations: (a) in the presence of activated I-Ab-reactive T cells, nontolerant, lysozyme-specific B cells expressing bA h made no Ab response unless they were also exposed to antigen; (b) under the same conditions, tolerant, lysozyme-spedfic B cells failed to respond even when exposed to lysozyme, and these cells lacked lysozyme-induced sIg signaling; (c) a more potent multivalent form of lysozyrrle, membrane lysozyme, was able to trigger some signaling through sIg in tolerant cells, and this markedly restored their ability to mount an Ab response in the presence of activated Th cells. (Figs. 3, B and C, and 4 C). Second, Dbl-transgenic B cells that had been parked in nontransgenic mice and that had recovered comparable HEL-binding capacity remained unable to increase [Call after HEL binding (Fig. 4 B) . Third, IgD receptors are expressed at identical levels on tolerant and nontolerant B cells and should be crosslinked identically after treatment with polydonal antisera to IgD or anti-IgD coupled to dextran. These stimuli nevertheless elicited markedly reduced proximal signaling and failed to induce mitogenesis in tolerant B cells (Fig. 5 C and D , and data not shown).
Basis for Blocked Signaling in
Given the evidence for a signaling block, the failure of antiIgD stimulation to induce G0-G1 transition or cell cycle entry in the tolerant B cells despite activating some tyrosine phosphorylation and calcium influx (Fig. 5) , could have implied a block downstream of these initial events. The fact that the tolerant B cells proliferated normally after stimulation with calcium ionophore and phorbol ester (Fig. 6 E) nevertheless argues against a downstream defect. Moreover, the short-lived calcium response induced by anti-IgD in the tolerant cells (Fig. 6 A) is most consistent with a receptorproximal defect, since coupling of [Call stores to cellular influx, as assessed by exposure to thapsigargin occurs normally in the tolerant B cells (Cooke, M.P., unpublished ob-
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Cooke et al. (45) . Indeed, the lack of response to weak stimuli (sHEL) and transient responses to strong stimuli (polyclonal anti-IgD) resembles the response to different anti-TCR Abs in mutant T cell lymphomas that lack a single component of the TCR signal-transduction complex, such as the tyrosine kinase p56 ~k (46) . Exactly how Ag binding induces slg signaling remains to be fully elucidated, although Ag-driven receptor dimerization or multimerization is thought to play an important role (for a review see reference 47). The ability of sHEL to trigger slg signaling is in this respect surprising, since sHEL is known to bind the transgene-encoded Ig as a monomer (48) . Many of the signaling events induced by sHEL (Figs. 4 and 5) nevertheless appear equivalent to those described for nonmitogenic monoclonal IgG Abs to IgM or IgD (for reviews see references 35 and 36) . We therefore favor the view that sHEL, like anti-Ig Abs, induces slg signaling by receptor dimerization. HEL-mediated dimerization could occur via preformed HEL dimers in solution or be driven by high local concentrations of receptor-bound HEL on the cell surface, since HEL dimerizes in solution at higher concentrations (49) . By comparison, the ability of polyvaleut ligands such as polyclonal anti-IgD and membrane-bound HEL to partially overcome the sHEL-induced signaling blockade may simply reflect more extensive slg multimerization induced by these ligands. Consistent with this notion, increasing the valency of initially oligovalent Ags or divalent anti-Ig Abs has been found to markedly increase their potency for B cell activation (39, 50) .
Since other B cell surface proteins such as CD19, CD21 (for reviews see references 51 and 52), and CD22 (53) may also participate in signaling by slg, it will be important to determine whether differences in their activity may contribute to the sIg signaling defect found in tolerant B cells. It will also be important to relate the regulation of sIg signaling in tolerant B cells to the interruption of sIg signaling induced in mature B cells by acute sIg cross-linking (54, 55) or by coligation with the Fc~ receptor (56, 57) , particularly since the latter is thought to provide an important negative feedback during Ab responses to foreign Ags (for a review see reference 58).
Role of slg Signaling in B-T Cell Interaction.
Whereas the role of slg in mediating Ag uptake for subsequent processing and presentation to Th cells is well established (9) (10) (11) (12) , the role of slg signal transduction in T cell-dependent Ab responses has remained unclear (59) (60) (61) (62) . In particular, it is difficult to reconcile the need for both MHC-restricted B cell Ag presentation and the need for slg signaling with recent studies demonstrating that, in the absence of both events, membrane CD40L together with T cell-derived lymphokines can nevertheless trigger resting B cells to proliferate and produce Ab efficiently (for a review see reference 7) .
A model to explain the requirement for sIg signaling and Reinduction of these growth and differentiation factors during B-T cell synapsis is hypothesized to require the T cell m be stimulated both by antigen peptide-MHC complexes engaging the TCK and by B cell activation molecules such as B7 engaging CD28, or other activation molecules (X) engaging receptor (R-X). T cell help is thus delivered sdectively to B cells that make Abs specific for foreign Ags, since only in these cells does the binding of Ag to slg allow both eificient uptake of Ag for presentation and trigger expression of B7 and other activation markers.
MHC-restricted Ag presentation in T cell-dependent Ab production is outlined in Hg. 8. The model assumes that T cell expression of CD40L after activation is transient, as has been shown in vitro (2) , requiring that CD40L be reinduced during T-B cell synapsis. Surface Ig on Ag-specific B cells may thus play two roles in reinducing CD40L, firstly by capturing Ag for effident processing and presentation to the TCK and second by triggering a marked increase in B ceil activation molecules such as B7 on the cell surface (63, and Fig. 3 ). Other activation molecules triggered by slg sighaling after Ag binding, simply denoted "X" in Fig. 8 , indude ICAM-1, (64, and Fig. 4 D) , CD44 (65, 66) , and LFA-1 (64) . The combined presence of specific peptide-MHC complexes and certain activation molecules on the B cell may be required to reinduce CD40L expression and other Th ceil functions. In support of this notion, B7 signaling through CD28 on the T cell is strongly synergistic with TCK signaling for restimulating T cell production of IL-2 (27, 6%71) and for stimulating re-expression of CD40L (Clark, E., personal communication). While the importance of CD28 costimulation during interaction between B ceils and T calls remains to be established, several lines of evidence suggest a pivotal role. In experiments here, induction of B7 or B7-related molecules on Ag-binding B cells correlated with their ability to mount an Ab response in the presence of activated I-Ab-specific T cells. Conversely, primary T ceil-dependent Ab responses in mice have been shown to be suppressed by blocking B7 or B7-rdated molecules with soluble CTLA4-Ig (72, 73) . Similarly, gene knockout mice lacking the CD28 receptor for B7 have greatly diminished T cell-dependent Ab responses but apparently normal cytotoxic and delayed-type hypersensitivity T cell responses (74) .
Based on the above, it willbe important to determine what effect is induced in Th ceils when bound Ag is presented by tolerant B cells that fail to signal through sIg and lack costimulatory molecules such as B7. We have recently established that tolerant Dbl-transgenic B cells do indeed process and present lysozyme efficiently to lysozyme-speciiic T ceils from a TCR gene transgenic mouse (Ho, W., M. M. Davis, M. P. Cooke, and C. C. Goodnow, unpublished observations). In contrast to presentation of Ag by nontolerant Igtransgenic B cells, however, the tolerant B cells fail to trigger T cell effector functions in vitro unless e~ogenous anti-CD28 Ab is provided, and the tolerant B cells still fail to be induced into proliferation or Ab production in vitro and in vivo. Since TCR signaling in the absence of costimulation through CD28 results in T cell anergy under some conditions (for reviews see references 75 and 76), it will be important to determine whether antigen presentation by tolerant B cells is neutral or has an active negative effect on Th cell function.
